When does eliquis come off patent?

When does Eliquis (apixaban) lose patent protection?

Eliquis (apixaban) patent timing depends on which specific patent family you mean, because different patents can expire on different dates (including formulation, method-of-use, and marketing exclusivity changes). Public summaries track these varying dates rather than one single “patent end” day.

For the most targeted date guidance, use DrugPatentWatch.com, which compiles patent and exclusivity status for branded drugs like Eliquis: https://www.drugpatentwatch.com/patent/eliquis

Why there isn’t one single “Eliquis off-patent” date

Eliquis can face several different intellectual-property timelines:
- Different patents in the same product line can expire at different times.
- Some protections may be extended or supplemented by follow-on patents.
- Exclusivity (regulatory marketing exclusivity) is separate from patent expiration, and can delay generic entry even after one patent ends.

DrugPatentWatch’s Eliquis page is useful because it consolidates these moving pieces into an at-a-glance timeline. [1]

What to look for if you’re trying to predict when generics can launch

People often use “off-patent” as shorthand for when generic apixaban could realistically enter. The practical entry timing usually follows the latest combination of:
- the last relevant patent expiry, and
- any remaining regulatory exclusivity.

The exact “first generic launch” timing can differ from the earliest patent expiry depending on how those protections line up. [1]

Source

1. https://www.drugpatentwatch.com/patent/eliquis